Mediators of nasal blockage in allergic rhinitis.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Allergy. European Journal of Allergy and Clinical Immunology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 9353555
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Histamine and the nasal vasculature: the influence of H1 and H2-histamine receptor antagonism.

  1996cited by this paper
• Selective recruitment of eosinophils by substance P after repeated allergen exposure in allergic rhinitis

  1995cited by this paper
• The cellular basis for allergic rhinitis

  1995cited by this paper
• Tryptase in nasal fluid is a useful marker of allergic rhinitis

  1993cited by this paper
• Comparative nasal effects of bradykinin and histamine: influence on nasal airways resistance and plasma protein exudation.

  1993cited by this paper
• Cytokine expression after the topical administration of substance P to human nasal mucosa. The role of substance P in nasal allergy.

  1993cited by this paper
• Substance P, calcitonin gene-related peptide, and vasoactive intestinal peptide increase in nasal secretions after allergen challenge in atopic patients.

  1993cited by this paper
• The temporal relationship between the neural and vascular actions of kallidin within the nose

  1993cited by this paper
• The effect of BAY u 3405, a thromboxane receptor antagonist, on prostaglandin D2-induced nasal blockage.

  1993cited by this paper
• Indirect evidence of nasal inflammation assessed by titration of inflammatory mediators and enumeration of cells in nasal secretions of patients with chronic rhinitis.

  1992cited by this paper
• Kinins and rhinitis

  1992cited by this paper
• Clinical and inflammatory responses to exogenous tachykinins in allergic rhinitis.

  1991cited by this paper
• Improvement of symptoms of non‐allergic chronic rhinitis by local treatment with capsaicin

  1991cited by this paper
• Study of the effects of paf‐acether on human nasal airways

  1991cited by this paper
• Substance P and neurokinin A in human nasal mucosa.

  1991cited by this paper
• Bradykinin and respiratory mucous membranes. Analysis of bradykinin binding site distribution and secretory responses in vitro and in vivo.

  1990cited by this paper
• Aqueous beclomethasone diproprionate nasal spray: regular versus "as required" use in the treatment of seasonal allergic rhinitis.

  1990cited by this paper
• Albumin, bradykinins, and eosinophil cationic protein on the nasal mucosal surface in patients with hay fever during natural allergen exposure.

  1990cited by this paper
• Physiologic responses to intranasal dose-response challenges with histamine, methacholine, bradykinin, and prostaglandin in adult volunteers with and without nasal allergy.

  1990cited by this paper
• Evidence of PAF-acether metabolic pathway activation in antigen challenge of upper respiratory airways.

  1989cited by this paper
• Allergic rhinitis: a rational choice of treatment.

  1989cited by this paper
• The role of leukotriene D4 in allergic rhinitis.

  1988cited by this paper
• Nasal response to substance P and methacholine in subjects with and without allergic rhinitis.

  1988cited by this paper
• Leukotriene C4 release in upper respiratory mucosa during natural exposure to ragweed in ragweed-sensitive children.

  1988cited by this paper
• A novel class (H3) of histamine receptors on perivascular nerve terminals

  1987cited by this paper
• Behavior and clinical relevance of histamine and leukotrienes C4 and B4 in grass pollen-induced rhinitis.

  1987cited by this paper
• The effects of combined H1 and H2 histamine antagonists on alterations in nasal airflow resistance induced by topical histamine provocation.

  1986cited by this paper
• Effect of leukotriene D4 on nasal mucosal blood flow, nasal airway resistance and nasal secretion in humans

  1986cited by this paper
• Inflammatory mediators in late antigen-induced rhinitis.

  1985cited by this paper
• Peptide leukotriene release after antigen challenge in patients sensitive to ragweed.

  1984cited by this paper
• Control of nasal vasculature and airflow resistance in the dog.

  1984cited by this paper
• Effect of Platelet Activating Factor on the Human Nasal Mucosa

  1984cited by this paper
• Local and systemic capsaicin pretreatment inhibits sneezing and the increase in nasal vascular permeability induced by certain chemical irritants

  1984cited by this paper
• Role of histamine and antihistamines in the nose.

  1983cited by this paper
• Increased vascular permeability in rat nasal mucosa induced by substance P and stimulation of capsaicin-sensitive trigeminal neurons.

  1983cited by this paper
• Kinins are generated in vivo following nasal airway challenge of allergic individuals with allergen.

  1983cited by this paper
• A sensitive and specific radiometric method for the measurement of plasma histamine in normal individuals.

  1980cited by this paper
• Distribution and clinical significance of the autonomic nervous system in the human nasal mucosa.

  1972cited by this paper

• LPCAT2 Methylation, a Novel Biomarker for the Severity of Cedar Pollen Allergic Rhinitis in Japan

  2020influential citation
• A randomized controlled phase II clinical trial comparing ONO‐4053, a novel DP1 antagonist, with a leukotriene receptor antagonist pranlukast in patients with seasonal allergic rhinitis

  2017cites this paper
• SECRETION SKN RRITANTS WITH FACIAL TISSUE

  2017cites this paper
• Leukotriene D4 nasal provocation test: Rationale, methodology and diagnostic value.

  2016cites this paper
• Correlations of nasal responses to leukotriene D4 and histamine nasal provocation with quality of life in allergic rhinitis

  2016cites this paper
• The comparision of the effica y of fluticasone propionate with ce irizi e i p renne l allergic rhinitis

  2014cites this paper
• Passive smoking and expired carbon monoxide concentrations in healthy and asthmatic children

  2014cites this paper
• Desloratadine‐montelukast combination improves quality of life and decreases nasal obstruction in patients with perennial allergic rhinitis

  2013cites this paper
• Phototherapy for the Treatment of Allergic Rhinitis

  2012cites this paper
• Histamine and Leukotriene Receptor Antagonism in the Treatment of Allergic Rhinitis

  2012cites this paper
• Allergic Rhinitis

  2012cites this paper
• The Future of ORL-HNSand Associated Specialties Series The future of rhinology, anterior skull base and facial plastic surgery

  2012cites this paper
• 11 Phototherapy for the Treatment of Allergic Rhinitis

  2012cites this paper
• [Histamine H₁ receptor gene as an allergic diseases-sensitive gene and its impact on therapeutics for allergic diseases].

  2011cites this paper
• What are the primary clinical symptoms of rhinitis and what causes them?

  2011cites this paper
• Current understanding of the pathophysiology of allergic rhinitis.

  2011cites this paper
• Pharmacological characterization of GSK1004723, a novel, long‐acting antagonist at histamine H1 and H3 receptors

  2011cites this paper
• Discovery of an Oral Potent Selective Inhibitor of Hematopoietic Prostaglandin D Synthase (HPGDS).

  2010cites this paper
• Rhinitis , sinusitis , and upper airway disease Nasal AMP and histamine challenge within and outside the pollen season in patients with seasonal allergic rhinitis

  2010cites this paper
• Rupatadine 10 mg in adolescent and adult symptom relief of perennial allergic rhinitis

  2010cites this paper
• Multiple action agents and the eye: do they really stabilize mast cells?

  2009cites this paper
• Suplatast Tosilate Inhibits Histamine Signaling by Direct and Indirect Down-Regulation of Histamine H1 Receptor Gene Expression through Suppression of Histidine Decarboxylase and IL-4 Gene Transcriptions1

  2009cites this paper
• Kujin suppresses histamine signaling at the transcriptional level in toluene 2,4-diisocyanate-sensitized rats.

  2009cites this paper
• Allergic rhinitis and sleep disorder

  2009cites this paper
• Evidence‐based recommendations regarding the differential diagnosis and assessment of nasal congestion: using the new GRADE system

  2008cites this paper
• Immunohistochemical localization of phospholipase A2 in the guinea pig nasal mucosa.

  2008cites this paper
• Effects of KP-496, a novel dual antagonist of leukotriene D4 and thromboxane A2 receptors on nasal blockage in guinea pig models of allergic rhinitis

  2008cites this paper
• Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update

  2008cites this paper
• Effectiveness of twice daily azelastine nasal spray in patients with seasonal allergic rhinitis

  2008cites this paper
• The roles of the prostaglandin D2 receptors DP1 and CRTH2 in promoting allergic responses

  2008cites this paper
• New insights into the pathophysiology of allergic rhinitis.

  2007cites this paper
• Azelastine hydrochloride:a review of pharmacology, pharmacokinetics, clinical efficacy and tolerability

  2007cites this paper
• Pathophysiology of nasal obstruction and meta‐analysis of early and late effects of levocetirizine

  2006cites this paper
• The importance of rhinitis on sleep, daytime somnolence, productivity and fatigue

  2006cites this paper
• Different mechanisms between thromboxane A2- and leukotriene D4-induced nasal blockage in guinea pigs.

  2006cites this paper
• Mast cell inhibitor R112 is well tolerated and affects prostaglandin D2 but not other mediators, symptoms, or nasal volumes in a nasal challenge model of allergic rhinitis.

  2006cites this paper
• A practical approach to allergic rhinitis and sleep disturbance management.

  2006cites this paper
• Increased expression of lipoxygenase enzymes during pollen season in nasal biopsies of pollen‐allergic patients

  2006cites this paper
• Roles of prostaglandin D2 and prostaglandin E2 in allergic reactions: pro-allergic and anti-allergic modulating pathways

  2006cites this paper
• An investigation into the actions of Bradykinin receptor antagonists as inhibitors of kallikrein and the generation of kinins within the human nasal airway.

  2006cites this paper
• Review of the pharmacology, clinical efficacy, and safety of azelastine hydrochloride

  2005cites this paper
• Suppression of allergic inflammation by the prostaglandin E receptor subtype EP3

  2005cites this paper
• [Oral second generation antihistamines in allergic rhinitis].

  2005cites this paper
• Role of histamine and platelet-activating factor in allergic rhinitis

  2004cites this paper
• Peptiderge Mediatoren und ihr Beitrag zur Pathophysiologie entzündlicher Erkrankungen

  2004cites this paper
• Inflammatory Responses in Allergic Rhinitis: Traditional Approaches and Novel Treatment Strategies

  2004cites this paper
• The correlation between allergic rhinitis and sleep disturbance.

  2004cites this paper
• Influences of Allergic Rhinitis on Sleep

  2004cites this paper
• Synergism between cysteinyl leukotrienes and thromboxane A2 to induce allergic late phase nasal blockage in guinea pigs.

  2004cites this paper
• Benzimidazoles as new potent and selective DP antagonists for the treatment of allergic rhinitis.

  2004cites this paper
• Montelukast plus cetirizine in the prophylactic treatment of seasonal allergic rhinitis: influence on clinical symptoms and nasal allergic inflammation

  2004cites this paper
• Inflammatory mediators in allergic rhinitis.

  2004cites this paper
• Allergic rhinitis: systemic inflammation and implications for management.

  2003cites this paper
• Epidermal growth factor receptor – but not histamine receptor – is upregulated in seasonal allergic rhinitis

  2003cites this paper
• Minimal persistent inflammation, an emerging concept in the nature and treatment of allergic rhinitis: the possible role of leukotrienes.

  2003cites this paper
• Allergic Rhinitis: Broader Disease Effects and Implications for Management

  2003cites this paper
• Expression of Cyclooxygenase-1 and -2 is Limited to the Nasal Glands in the Guinea Pig Nasal Cavity

  2003cites this paper
• Nasal blockage and urinary leukotriene E4 concentration in patients with seasonal allergic rhinitis

  2003cites this paper
• Fluticasone propionate aqueous nasal spray provided significantly greater improvement in daytime and nighttime nasal symptoms of seasonal allergic rhinitis compared with montelukast.

  2003cites this paper
• The use of prostaglandin D2 receptor antagonists to treat allergic rhinitis

  2003cites this paper
• A randomized comparison of the effects of budesonide and mometasone furoate aqueous nasal sprays on nasal peak flow rate and symptoms in perennial allergic rhinitis.

  2002cites this paper
• Pharmacological, pharmacokinetic and clinical properties of olopatadine hydrochloride, a new antiallergic drug.

  2002cites this paper
• The use of DP receptor antagonists to treat allergic rhinitis

  2002cites this paper
• Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis.

  2002cites this paper
• The comparison of the efficacy of fluticasone propionate with cetirizine in perennial allergic rhinitis.

  2001cites this paper
• Allergic rhinitis and its impact on asthma.

  2001cites this paper
• Involvement of neuropeptides in the allergic nasal obstruction in guinea pigs.

  2001cites this paper
• Prostaglandin D2 as a mediator of allergic asthma.

  2000cites this paper
• Nasal Airflow in Health and Disease

  2000cites this paper
• Allergic rhinitis: not purely a histamine‐related disease

  2000cites this paper
• The future of ORL-HNS and associated specialties series. The future of rhinology, anterior skull base and facial plastic surgery.

  2000cites this paper
• A 12‐week, placebo‐controlled study of the efficacy and safety of ebastine, 10 and 20 mg once daily, in the treatment of perennial allergic rhinitis

  1999cites this paper
• Clinical manifestations of the release of histamine and other inflammatory mediators.

  1999cites this paper
• EFFECTS OF ARACHIDONIC ACID METABOLITES ON NASAL MUCOSAL BLOOD FLOW

  1999cites this paper
• Leukotriene D 4 nasal provocation test : Rationale , methodology and diagnostic value

  year unknowncites this paper